Publications
(rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell line. Oncotarget.
Issue #7:79388-79400, 2016
Author:Prasad A1., Khudaynazar N1., Kuzontkoski P2., Tantravahi,V2. Gillum M. A2. ON 01910.Na